Showing results (2461-2470 of 3,087) with videos related to

Sort By:
Pageof 309
Drug Safety|July 20, 2015
Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials DatabasePaul B Watkins, James H Lewis, Neil Kaplowitz, et al.
Drug Safety|July 20, 2015
Selective Serotonin Reuptake Inhibitor Use and Perioperative Bleeding and Mortality in Patients Undergoing Coronary Artery Bypass Grafting: A Cohort StudyJoshua J Gagne, Jennifer M Polinski, Jeremy A Rassen, et al.
Drug Safety|September 2, 2025
Exploring the Reliability of Detecting Drug-Drug Interactions that Increase the Risk of Gestational Diabetes in Adverse Event Reporting SystemsRobiyanto Robiyanto, Jim W Barrett, Lovisa Sandberg, et al.
Drug Safety|September 3, 2025
Implementation and Results of Active Vaccine Safety Monitoring During the COVID-19 Pandemic in the UK: A Regulatory PerspectiveJenny Wong, Katherine Donegan, Kendal Harrison, et al.
Drug Safety|July 4, 2015
Hepatotoxicity of New Oral Anticoagulants (NOACs)Evangelia Liakoni, Alexandra E Rätz Bravo, Stephan Krähenbühl
Drug Safety|June 24, 2015
Primary Care Medication Safety Surveillance with Integrated Primary and Secondary Care Electronic Health Records: A Cross-Sectional StudyArtur Akbarov, Evangelos Kontopantelis, Matthew Sperrin, et al.
Drug Safety|June 26, 2015
Evaluating AE Reporting of Two Off-Patent Biologics to Inform Future Biosimilar Naming and Reporting PracticesStella Stergiopoulos, Kenneth Getz
Drug Safety|August 12, 2021
Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec TherapyJohn W Day, Jerry R Mendell, Eugenio Mercuri, et al.
Drug Safety|May 24, 2020
Information Visualization Platform for Postmarket Surveillance Decision SupportJonathan Spiker, Kory Kreimeyer, Oanh Dang, et al.
Drug Safety|August 17, 2022
Analytical Approaches to Reduce Selection Bias in As-Treated Analyses with Missing In-Hospital Drug InformationYeon-Hee Baek, Yunha Noh, In-Sun Oh, et al.
Pageof 309